Clinical Trial Update: Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating preoperative chemotherapy for triple-negative invasive breast cancer that can be removed by surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: University of Tennessee Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN